A collagen-binding interleukin-12 formulation intravenously injected into mice bearing established immunologically cold mouse tumours led to marked tumour remission, particularly when combined with checkpoint-inhibitor immunotherapy.
- Aslan Mansurov
- Jun Ishihara
- Jeffrey A. Hubbell
